Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Smoking and mechanisms of cardiovascular control.

Robertson D, Tseng CJ, Appalsamy M.

Am Heart J. 1988 Jan;115(1 Pt 2):258-63. Review.

PMID:
3276114
2.

Effects of nicotine on brain stem mechanisms of cardiovascular control.

Tseng CJ, Appalsamy M, Robertson D, Mosqueda-Garcia R.

J Pharmacol Exp Ther. 1993 Jun;265(3):1511-8.

PMID:
8099622
3.

Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon.

Chadman KK, Woods JH.

J Pharmacol Exp Ther. 2004 Jan;308(1):73-8. Epub 2003 Oct 17.

4.

Dose-related cardiovascular and endocrine effects of transdermal nicotine.

Zevin S, Jacob P 3rd, Benowitz NL.

Clin Pharmacol Ther. 1998 Jul;64(1):87-95.

PMID:
9695723
5.

Combined effects of cocaine and nicotine on cardiovascular performance in a canine model.

Mehta MC, Jain AC, Billie MD.

Clin Cardiol. 2001 Sep;24(9):620-6.

6.

Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.

Khan IM, Taylor P, Yaksh TL.

J Pharmacol Exp Ther. 1994 Jul;270(1):150-8.

PMID:
8035311
7.

Cardiovascular effects of nicotine during physical activity and following meal consumption.

Perkins KA, Epstein LH, Stiller RL, Sexton JE, Marks BL, Jacob RG.

Clin Exp Pharmacol Physiol. 1990 May;17(5):327-34.

PMID:
2354552
8.

The cardiovascular interaction between caffeine and nicotine in humans.

Smits P, Temme L, Thien T.

Clin Pharmacol Ther. 1993 Aug;54(2):194-204.

PMID:
8354027
9.

New insights into the sympathetic, endothelial and coronary effects of nicotine.

Adamopoulos D, van de Borne P, Argacha JF.

Clin Exp Pharmacol Physiol. 2008 Apr;35(4):458-63. doi: 10.1111/j.1440-1681.2008.04896.x. Review.

PMID:
18307741
10.

Blood levels of nicotine and physiological effects after inhalation of tobacco smoke.

Isaac PF, Rand MJ.

Eur J Pharmacol. 1969 Dec;8(3):269-83. No abstract available.

PMID:
5370227
11.

The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects.

Perkins KA, Fonte C, Stolinski A, Blakesley-Ball R, Wilson AS.

Exp Clin Psychopharmacol. 2005 Nov;13(4):275-81.

PMID:
16366757
12.

Effects of chronic smoke exposure on the cardiovascular responses to acute nicotine infusion in the rat.

Barron KW, Heesch CM, Fleming BP, Chien CY, Diana JN.

Eur J Pharmacol. 1988 Feb 9;146(2-3):237-45.

PMID:
3371398
15.

A study on possible modulating and direct effects of gamma2-MSH and ACTH-(1-24) on the cardiovascular system of the rat.

Van Bergen P, Vleeming W, Van Heijst BG, Versteeg DH, De Wildt DJ.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Aug;358(2):220-9.

PMID:
9750008
16.
17.

Stimulatory pathways and sites of action of intrathecally administered nicotinic agents.

Khan IM, Taylor P, Yaksh TL.

J Pharmacol Exp Ther. 1994 Dec;271(3):1550-7.

PMID:
7996469
18.

Pressor effects of noradrenaline injected into the lateral septal area of unanesthetized rats.

Scopinho AA, Resstel LB, Antunes-Rodrigues J, CorrĂȘa FM.

Brain Res. 2006 Nov 29;1122(1):126-34. Epub 2006 Oct 2.

PMID:
17011526
19.
20.

Neurobehavioral mechanisms of nicotine action: role in the initiation and maintenance of tobacco dependence.

Rosecrans JA, Karan LD.

J Subst Abuse Treat. 1993 Mar-Apr;10(2):161-70. Review.

PMID:
8510190

Supplemental Content

Support Center